Search

Table S1 - List of antibodies used

The aggressive primary brain tumor glioblastoma (GBM) is characterized by aberrant metabolism that fuels its malignant phenotype. Diverse genetic subtypes of malignant glioma are sensitive to selective inhibition of the NAD+ salvage pathway enzyme nicotinamide phosphoribosyltransferase (NAMPT). However, the potential impact of NAD+ depletion on the brain tumor microenvironment has not been elaborated. In addition, systemic toxicity of NAMPT inhibition remains a significant concern. Here we show that microparticle-mediated intratumoral delivery of NAMPT inhibitor GMX1778 induces specific immunologic changes in the tumor microenvironment of murine GBM, characterized by upregulation of immune checkpoint PD-L1, recruitment of CD3+, CD4+, and CD8+ T cells, and reduction of M2-polarized immunosuppressive macrophages. NAD+ depletion and autophagy induced by NAMPT inhibitors mediated the upregulation of PD-L1 transcripts and cell surface protein levels in GBM cells. NAMPT inhibitor modulation of the tumor immune microenvironment was therefore combined with PD-1 checkpoint blockade in vivo, significantly increasing the survival of GBM-bearing animals. Thus, the therapeutic impacts of NAMPT inhibition extended beyond neoplastic cells, shaping surrounding immune effectors. Microparticle delivery and release of NAMPT inhibitor at the tumor site offers a safe and robust means to alter an immune tumor microenvironment that could potentiate checkpoint immunotherapy for glioblastoma.Significance:Microparticle-mediated local inhibition of NAMPT modulates the tumor immune microenvironment and acts cooperatively with anti-PD-1 checkpoint blockade, offering a combination immunotherapy strategy for the treatment of GBM.

Supplemental figures 1-10. Supplementary Figure S1. Cell viability assay with NAMPT inhibitors. Supplementary Figure S2. NAMPT inhibitor induces PD-L1 upregulation on alive cells. Supplementary Figure S3. NAMPT inhibitor induces PD-L1 upregulation. Supplementary Figure S4. Tumor PD-L1 upregulation after injection of coumarin6GMX1778 co-loaded microparticles. Supplementary Figure S5. NAMPT inhibitor-induced autophagy underlies an increase in PD-L1 mRNA and protein levels. Supplementary Figure S6. Impact of local treatment with GMX1778 microparticles on cells labeled with Arg1 and CD68 in murine glioblastoma. Supplementary Figure S7. NAMPT inhibitor decreases glioblastoma-associated macrophages. Supplementary Figure S8. PD-L1 immunohistochemistry (brown) of GL261 glioblastoma after treatment with blank micro-particles (MP), blank MP and anti-PD-1, GMX1778 MP, and combination of GMX1778 MP and anti-PD-1. Supplementary Figure S9. Immunoflurescence of GL261 glioblastoma after treatment with blank micro-particles, anti-PD-1, GMX1778 micro-particles, and combination. Supplementary Figure S10. GranzymeB immunohistochemistry (brown) of GL261 glioblastoma after treatment with blank micro-particles (MP), blank MP and anti-PD-1, GMX1778 MP, and combination of GMX1778 MP and anti-PD-1.

Tablets and capsules are a cornerstone of medicine, but these solid dosage forms can be challenging to swallow for geriatric and pediatric patients. While liquid formulations are easier to ingest, these formulations lack the capacity to localize therapeutics and excipients nor act as controlled release devices. To bridge the advantages of solid and liquid dosage forms, here we describe drug formulations based on liquidin situ-forming and tough (LIFT) hydrogels. Drug-loaded LIFT hydrogels are formed directly in the stomach through the sequential ingestion of a crosslinker solution of calcium and dithiol crosslinkers, followed by the ingestion of a drug-containing polymer solution of alginate and 4-arm poly(ethylene glycol)-maleimide. We show that LIFT hydrogels are mechanically tough and able to robustly form in the presence of complex gastric fluid andin vivoin rat and porcine stomachs. LIFT hydrogels are retained within the porcine stomach for up to 24 h, biocompatible, and safely cleared. These hydrogels deliver a total dose comparable to unencapsulated drug but with delayed and lower maximum drug plasma concentrations, providing a method for controlled release that may mitigate drug toxicity. Co-encapsulation of lactase as a model biologic drug and calcium carbonate mitigated gastric-mediated deactivation of encapsulated enzyme in rat and porcine models. We also demonstrate the potential of these hydrogels to encapsulate and protect a model therapeutic bacterium,E. coliNissle 1917, against acid. LIFT hydrogels present a biocompatible means of tough, double-network hydrogel formationin situin the gastric cavity, and may expand medication access for patients with difficulty swallowing.

Implantable drug depots have the capacity to locally meet therapeutic requirements by maximizing local drug efficacy and minimizing potential systemic side effects. Tubular organs including the gastrointestinal tract, respiratory tract and vasculature all manifest with endoluminal disease. The anatomic distribution of localized drug delivery for these organs using existing therapeutic modalities is limited. Application of local depots in a circumferential and extended longitudinal fashion could transform our capacity to offer effective treatment across a range of conditions. Here we report the development and application of a kirigami-based stent platform to achieve this. The stents comprise a stretchable snake-skin-inspired kirigami shell integrated with a fluidically driven linear soft actuator. They have the capacity to deposit drug depots circumferentially and longitudinally in the tubular mucosa of the gastrointestinal tract across millimetre to multi-centimetre length scales, as well as in the vasculature and large airways. We characterize the mechanics of kirigami stents for injection, and their capacity to engage tissue in a controlled manner and deposit degradable microparticles loaded with therapeutics by evaluating these systems ex vivo and in vivo in swine. We anticipate such systems could be applied for a range of endoluminal diseases by simplifying dosing regimens while maximizing drug on-target effects through the sustained release of therapeutics and minimizing systemic side effects. A kirigami-inspired stent-based system has been developed for extended local drug delivery to the gastrointestinal and respiratory tracts as well as the vascular system.

Carbon monoxide (CO) has long been considered a toxic gas but is now a recognized bioactive gasotransmitter with potent immunomodulatory effects. Although inhaled CO is currently under investigation for use in patients with lung disease, this mode of administration can present clinical challenges. The capacity to deliver CO directly and safely to the gastrointestinal (GI) tract could transform the management of diseases affecting the GI mucosa such as inflammatory bowel disease or radiation injury. To address this unmet need, inspired by molecular gastronomy techniques, we have developed a family of gas-entrapping materials (GEMs) for delivery of CO to the GI tract. We show highly tunable and potent delivery of CO, achieving clinically relevant CO concentrations in vivo in rodent and swine models. To support the potential range of applications of foam GEMs, we evaluated the system in three distinct disease models. We show that a GEM containing CO dose-dependently reduced acetaminophen-induced hepatocellular injury, dampened colitis-associated inflammation and oxidative tissue injury, and mitigated radiation-induced gut epithelial damage in rodents. Collectively, foam GEMs have potential paradigm-shifting implications for the safe therapeutic use of CO across a range of indications.

The aggressive primary brain tumor glioblastoma (GBM) is characterized by aberrant metabolism that fuels its malignant phenotype. Diverse genetic subtypes of malignant glioma are sensitive to selective inhibition of the NAD+ salvage pathway enzyme nicotinamide phosphoribosyltransferase (NAMPT). However, the potential impact of NAD+ depletion on the brain tumor microenvironment has not been elaborated. In addition, systemic toxicity of NAMPT inhibition remains a significant concern. Here we show that microparticle-mediated intratumoral delivery of NAMPT inhibitor GMX1778 induces specific immunologic changes in the tumor microenvironment of murine GBM, characterized by upregulation of immune checkpoint PD-L1, recruitment of CD3+, CD4+, and CD8+ T cells, and reduction of M2-polarized immunosuppressive macrophages. NAD+ depletion and autophagy induced by NAMPT inhibitors mediated the upregulation of PD-L1 transcripts and cell surface protein levels in GBM cells. NAMPT inhibitor modulation of the tumor immune microenvironment was therefore combined with PD-1 checkpoint blockade in vivo, significantly increasing the survival of GBM-bearing animals. Thus, the therapeutic impacts of NAMPT inhibition extended beyond neoplastic cells, shaping surrounding immune effectors. Microparticle delivery and release of NAMPT inhibitor at the tumor site offers a safe and robust means to alter an immune tumor microenvironment that could potentiate checkpoint immunotherapy for glioblastoma. Significance: Microparticle-mediated local inhibition of NAMPT modulates the tumor immune microenvironment and acts cooperatively with anti-PD-1 checkpoint blockade, offering a combination immunotherapy strategy for the treatment of GBM.

Administering medicines to 0- to 5-year-old children in a resource-limited environment requires dosage forms that circumvent swallowing solids, avoid on-field reconstitution, and are thermostable, cheap, versatile, and taste masking. We present a strategy that stands to solve this multifaceted problem. As many drugs lack adequate water solubility, our formulations used oils, whose textures could be modified with gelling agents to form "oleogels." In a clinical study, we showed that the oleogels can be formulated to be as fluid as thickened beverages and as stiff as yogurt puddings. In swine, oleogels could deliver four drugs ranging three orders of magnitude in their water solubilities and two orders of magnitude in their partition coefficients. Oleogels could be stabilized at 40 degrees C for prolonged durations and used without redispersion. Last, we developed a macrofluidic system enabling fixed and metered dosing. We anticipate that this platform could be adopted for pediatric dosing, palliative care, and gastrointestinal disease applications., Science Advances, 8 (21), ISSN:2375-2548

A one-pot soft-templating method is reported to fabricate nanosized bimetallic PdAg hollow mesoporous nanospheres (HMSs) for electrocatalytic ethanol oxidation reaction (EOR). The synthesis relies on the "dual-template" surfactant of dioctadecyldimethylammonium chloride that drives in situ growth of mesoporous frameworks on the surface of vesicles into the HMSs with radially opened mesochannels. The synthetic protocol is extendable to engineer elemental compositions and hierarchical nanostructures of PdAg nanoalloys. This system thus provides a direct yet solid platform to understand catalytic add-in synergies of PdAg HMSs toward electrochemical EOR. By evaluating compositional and structural features separately, bimetallic Pd65Ag35 HMSs display the highest EOR activity with a mass activity of 4.61 A mgPd-1. Mechanism studies indicate that synergistically electronic and bifunctional effects as well as structural advantages of Pd65Ag35 HMSs kinetically optimize the removal of poisoning carbonaceous intermediates and accelerate the diffusion processes (the rate-determining step), and thus promote the EOR performance accordingly.

Rational design and synthesis of highly efficient nanocatalysts towards electrochemical ethanol oxidation reaction (EOR) are of great importance for practical applications in direct ethanol fuel cells. Nanoengineering the nanostructures and compositions of EOR electrocatalysts has been of significnat interest because these paratmeters can enhance electrocatalytic kinetics and performance in the EOR. This article reports a synergistic EOR catalyst with remarkably enhanced electrochemical performance based on 3-nm-thick bimetallic PdAg single-crystalline nanowires. Kinetically stable yet thermodynamically unfavorable ultrathin PdAg single-crystalline nanowires (sNWs) are epitaxially grown in situ along nanoconfined hexagonal mesophases directly self-assembled by amphiphilic surfactants of dioctadecyldimethylammonium chloride under optimal synthetic condtions in aqueous solution. Due to the ultrathin and ultralong nanostructure, single-crystalline feature with a high density of low-coordinate atomic steps, high Pd utilization efficiency, and incorporation of more oxophilic Ag with Pd, PdAg sNWs show enhanced mass activity of 2.84 A mgPd−1 and stability (retained 43% after 2500 cycles) in the EOR. The kinetic studies reveal that significant enhancement in EOR performance can be ascribed to the synergic electronic and bifunctional effects of ultrathin PdAg sNWs.

Mesoporous colloidal nanospheres with tailorable asymmetric nanostructures and multimetallic elemental compositions are building blocks in next-generation heterogeneous catalysts. Introducing structural asymmetry into metallic mesoporous frameworks has never been demonstrated, but it would be beneficial because the asymmetry enables the spatial control of catalytic interfaces, facilitates the electron/mass transfer and assists in the removal of poisonous intermediates. Herein, we describe a simple bottom-up strategy to generate uniform sub-100 nm multimetallic asymmetric bowl-shaped mesoporous nanospheres (BMSs). This method uses a surfactant-directed "dual"-template to control the kinetics of metal reduction on the surface of a vesicle, forming mesoporous metal islands on its surface whose spherical cone angle can be precisely controlled. The asymmetric BMS mesostructures with different spherical cone angles (structural asymmetries) and elemental compositions are demonstrated. The high surface area and asymmetric nature of the metal surfaces are shown to enhance catalytic performance in the alcohol oxidation reactions. The findings described here offer novel and interesting opportunities for rational design and synthesis of hierarchically asymmetric nanostructures with desired functions for a wide range of applications.

We report polymer-promoted cooperative catalysis of Cu for oxygen activation. A series of random copolymers containing dipicolylamine as binding motifs are designed to coordinate type-3 Cu sites. The Cu-copolymers show a 6–8-fold activity enhancement, compared to the molecular complex of Cu with an identical coordination site. Michaelis–Menten analysis demonstrates that the kinetic enhancement results from flexible polymer-promoted cooperative catalysis among multi-Cu sites despite the imposed thermodynamic barrier. These observations provide guidance for the bioinspired design of metallopolymers as soluble catalysts with high activity.

Mesoporous gold (mesoAu) nanospheres support enhanced (electro)catalytic performance owing to their three-dimensional (3D) interior mesochannels that expose abundant active sites and facilitate electron/mass transfers. Although various porous Nanostructured Au has been fabricated by electrochemical reduction, alloying–dealloying and hard/soft templating methods, successful synthesis of mesoAu nanospheres with tailorable sizes and porosities remains a big challenge. Here we describe a novel surfactant-directed synthetic route to fabricate mesoAu nanospheres with 3D interconnected mesochannels by using the amphiphilic surfactant of C22H45N+(CH3)2–C3H6–SH (Cl−) (C22N–SH) as the mesopore directing agent. C22N–SH can not only self-reduce trivalent Au(III)Cl4− to monovalent Au(I), but also form polymeric C22N–S–Au(I) intermediates via covalent bonds. These C22N–S–Au(I) intermediates facilitate the self-assembly into spherical micelles and inhibit the mobility of Au precursors, enabling the crystallization nucleation and growth of the mesoAu nanospheres via in situ chemical reduction. The synthetic strategy can be further extended to tailor the sizes/porosities and surface optical properties of the mesoAu nanospheres. The mesoAu nanospheres exhibit remarkably enhanced mass/specific activity and improved stability in methanol electrooxidation, demonstrating far better performance than non-porous Au nanoparticles and previously reported Au nanocatalysts. The synthetic route differs markedly from other long-established soft-templating approaches, providing a new avenue to grow metal nanocrystals with desirable nanostructures and functions.

Intravesical instillation is an efficient drug delivery route for the local treatment of various urological conditions. Nevertheless, intravesical instillation is associated with several challenges, including pain, urological infection, and frequent clinic visits for catheterization; these difficulties support the need for a simple and easy intravesical drug delivery platform. Here, we propose a novel biodegradable intravesical device capable of long-term, local drug delivery without a retrieval procedure. The intravesical device is composed of drug encapsulating biodegradable polycaprolactone (PCL) microcapsules and connected by a bioabsorbable Polydioxanone (PDS) suture with NdFeB magnets in the end. The device is easily inserted into the bladder and forms a 'ring' shape optimized for maximal mechanical stability as informed by finite element analysis. In this study, inserted devices were retained in a swine model for 4 weeks. Using this device, we evaluated the system's capacity for delivery of lidocaine and resiquimod and demonstrated prolonged drug release. Moreover, a cost-effectiveness analysis supports device implementation compared to the standard of care. Our data support that this device can be a versatile drug delivery platform for urologic medications.

The aggressive primary brain tumor glioblastoma (GBM) is characterized by aberrant metabolism that fuels its malignant phenotype. Diverse genetic subtypes of malignant glioma are sensitive to selective inhibition of the NAD+ salvage pathway enzyme nicotinamide phosphoribosyltransferase (NAMPT). However, the potential impact of NAD+ depletion on the brain tumor microenvironment has not been elaborated. In addition, systemic toxicity of NAMPT inhibition remains a significant concern. Here we show that microparticle-mediated intratumoral delivery of NAMPT inhibitor GMX1778 induces specific immunological changes in the tumor microenvironment of murine GBM, characterized by upregulation of immune checkpoint PD-L1, recruitment of CD3+, CD4+, and CD8+ T cells, and reduction of M2-polarized immunosuppressive macrophages. NAD+ depletion and autophagy induced by NAMPT inhibitors mediated the upregulation of PD-L1 transcripts and cell surface protein levels in GBM cells. NAMPT inhibitor modulation of the tumor immune microenvironment was therefore combined with PD-1 checkpoint blockade in vivo, significantly increasing the survival of GBM bearing animals. Thus, the therapeutic impacts of NAMPT inhibition extended beyond neoplastic cells, shaping surrounding immune effectors. Microparticle delivery and release of NAMPT inhibitor at the tumor site offers a safe and robust means to alter an immune tumor microenvironment that could potentiate checkpoint immunotherapy for glioblastoma.

Introduction Bile acids, such as chenodeoxycholic acid, play an important role in digestion but are also involved in intestinal motility, fluid homeostasis, and humoral activity. Colonic delivery of sodium chenodeoxycholate (CDC) has demonstrated clinical efficacy in treating irritable bowel syndrome with constipation but was associated with a high frequency of abdominal pain. We hypothesized that these adverse effects were triggered by local super-physiological CDC levels caused by an unfavorable pharmacokinetic profile of the delayed release formulation. Methods We developed novel release matrix systems based on hydroxypropyl methylcellulose (HPMC) for sustained release of CDC. These included standard HPMC formulations as well as bi-layered formulations to account for potential delivery failures due to low colonic fluid in constipated patients. We evaluated CDC release profiles in silico (pharmacokinetic modeling), in vitro and in vivo in swine (pharmacokinetics, rectal manometry). Results For the delayed release formulation in vitro release studies demonstrated pH triggered dose dumping which was associated with giant colonic contractions in vivo. Release from the bi-layered HPMC systems provided controlled release of CDC while minimizing the frequency of giant contractions and providing enhanced exposure as compared to standard HPMC formulations in vivo. Discussion Bi-phasic CDC release could help treat constipation while mitigating abdominal pain observed in previous clinical trials. Further studies are necessary to demonstrate the therapeutic potential of these systems in humans.

Implantable drug depots have the capacity to locally meet therapeutic requirements by maximizing local drug efficacy and minimizing potential systemic side effects. Tubular organs including the gastrointestinal tract, respiratory tract and vasculature all manifest with endoluminal disease. The anatomic distribution of localized drug delivery for these organs using existing therapeutic modalities is limited. Application of local depots in a circumferential and extended longitudinal fashion could transform our capacity to offer effective treatment across a range of conditions. Here we report the development and application of a kirigami-based stent platform to achieve this. The stents comprise a stretchable snake-skin-inspired kirigami shell integrated with a fluidically driven linear soft actuator. They have the capacity to deposit drug depots circumferentially and longitudinally in the tubular mucosa of the gastrointestinal tract across millimetre to multi-centimetre length scales, as well as in the vasculature and large airways. We characterize the mechanics of kirigami stents for injection, and their capacity to engage tissue in a controlled manner and deposit degradable microparticles loaded with therapeutics by evaluating these systems ex vivo and in vivo in swine. We anticipate such systems could be applied for a range of endoluminal diseases by simplifying dosing regimens while maximizing drug on-target effects through the sustained release of therapeutics and minimizing systemic side effects.

Epithelial tissues line the organs of the body, providing an initial protective barrier as well as a surface for nutrient and drug absorption. Here we identified enzymatic components present in the gastrointestinal epithelium that can serve as selective means for tissue-directed polymerization. We focused on the small intestine, given its role in drug and nutrient absorption, and identified catalase as an essential enzyme with the potential to catalyze polymerization and growth of synthetic biomaterial layers. We demonstrated that the polymerization of dopamine by catalase yields strong tissue adhesion. We characterized the mechanism and specificity of the polymerization in segments of the gastrointestinal tracts of pigs and humans ex vivo. Moreover, we demonstrated proof-of-concept for application of these gastrointestinal synthetic epithelial linings (GSELs) for drug delivery, enzymatic immobilization for digestive supplementation, and nutritional modulation through transient barrier formation in pigs. This catalase-based approach to in situ biomaterial generation may have broad indications for gastrointestinal applications.

Chronic hepatitis C virus (HCV) infection is a leading cause of cirrhosis worldwide and kills more Americans than 59 other infections, including HIV and tuberculosis, combined. While direct-acting antiviral (DAA) treatments are effective, limited uptake of therapy, particularly in high-risk groups, remains a substantial barrier to eliminating HCV. We developed a long-acting DAA system (LA-DAAS) capable of prolonged dosing and explored its cost-effectiveness. We designed a retrievable coil-shaped LA-DAAS compatible with nasogastric tube administration and the capacity to encapsulate and release gram levels of drugs while resident in the stomach. We formulated DAAs in drug-polymer pills and studied the release kinetics for 1 mo in vitro and in vivo in a swine model. The LA-DAAS was equipped with ethanol and temperature sensors linked via Bluetooth to a phone application to provide patient engagement. We then performed a cost-effectiveness analysis comparing LA-DAAS to DAA alone in various patient groups, including people who inject drugs. Tunable release kinetics of DAAs was enabled for 1 mo with drug-polymer pills in vitro, and the LA-DAAS safely and successfully provided at least month-long release of sofosbuvir in vivo. Temperature and alcohol sensors could interface with external sources for at least 1 mo. The LA-DAAS was cost-effective compared to DAA therapy alone in all groups considered (base case incremental cost-effectiveness ratio $39,800). We believe that the LA-DAA system can provide a cost-effective and patient-centric method for HCV treatment, including in high-risk populations who are currently undertreated.

Au is one of the most promising electrocatalysts to convert CO2 into CO in an aqueous-phase electrochemical reduction. However, ultrasmall Au nanocatalysts (AuNCs

The rational design of the Au–support electronic interaction is crucial for Au nanocatalysis. We herein report our observation of electronic perturbation at the Au–carbon interface and its application in controlling the reaction selectivity in styrene oxidation. Ultrasmall Au nanocatalysts were grown in situ on a nitrided carbon support where the nitrogen-doped carbon supports enriched the surface charge density and generated electron-rich Au surface sites. The Au–carbon interaction altered the binding behavior of C═C bonds to catalytic centers, leading to a solvent-polarity-dependent selectivity in C═C oxidation reactions. A high selectivity of 90% to benzaldehyde was achieved in an apolar solvent, and a selectivity of 95% to styrene epoxide was attained in a polar solvent. The Au–carbon electronic perturbation, originating from surface functional groups on the carbon support, may provide an alternative avenue to tune the selectivity and activity of more complex reactions in heterogeneous catalysis.

A general synthetic methodology is reported to grow ultrafine cobalt-based nanoparticles (NPs, 2–7 nm) within high-surface-area mesoporous carbon (MC) frameworks. Our design strategy is based on colloidal amphiphile (CAM) templated oxidative self-polymerization of dopamine. The CAM templates consisting of a hydrophobic silica-like core and a hydrophilic PEO shell can coassemble with dopamine and template its self-polymerization to form polydopamine (PDA) nanospheres. Given that PDA has rich binding sites such as catechol and amine to coordinate metal ions (e.g., Co2+), PDA nanospheres containing Co2+ ions can be converted into hierarchical porous carbon frameworks containing ultrafine metallic Co NPs (Co@MC) using high-temperature pyrolysis. The CAM templates offer strong “nanoconfinements” to prevent the overgrowth of Co NPs within carbon frameworks. The yielded ultrafine Co NPs have an average size of

Poor patient adherence to oral contraceptives is the predominant cause of failure of these therapies, leading to unplanned pregnancies that can negatively affect female health worldwide. To improve patient adherence, we developed an oral contraceptive that is administered once a month. Here, we describe the design and report in vivo characterization of a levonorgestrel-releasing gastric resident dosage form in pigs., Bill & Melinda Gates Foundation (Grant OPP1139927)

Nanoformulations are transforming our capacity to effectively deliver and treat a myriad of conditions. However, many nanoformulation approaches still suffer from high production complexity and low drug loading. One potential solution relies on harnessing co-assembly of drugs and small molecular excipients to facilitate nanoparticle formation through solvent exchange without the need for chemical synthesis, generating nanoparticles with up to 95% drug loading. However, there is currently no understanding which of the millions of possible combinations of small molecules can result in the formation of these nanoparticles. Here we report the development of a high-throughput screening platform coupled to machine learning to enable the rapid evaluation of such nanoformulations. Our platform identified 101 novel self-assembling drug nanoparticles from 2.1 million pairings derived from 788 candidate drugs with one of 2686 excipients, spanning treatments for multiple diseases and often harnessing well-known food additives, vitamins, or approved drugs as carrier materials – with potential for accelerated approval and translation. Given their long-term stability and potential for clinical impact, we further characterize novel sorafenib-glycyrrhizin and terbinafine-taurocholic acid nanoparticles ex vivo and in vivo. We anticipate that this platform could accelerate the development of safer and more efficacious nanoformulations with high drug loadings for a wide range of therapeutics.

Multigram drug depot systems for extended drug release could transform our capacity to effectively treat patients across a myriad of diseases. For example, tuberculosis (TB) requires multimonth courses of daily multigram doses for treatment. To address the challenge of prolonged dosing for regimens requiring multigram drug dosing, we developed a gastric resident system delivered through the nasogastric route that was capable of safely encapsulating and releasing grams of antibiotics over a period of weeks. Initial preclinical safety and drug release were demonstrated in a swine model with a panel of TB antibiotics. We anticipate multiple applications in the field of infectious diseases, as well as for other indications where multigram depots could impart meaningful benefits to patients, helping maximize adherence to their medication.

We report polymer-promoted cooperative catalysis of Cu for oxygen activation. A series of random copolymers containing dipicolylamine as binding motifs are designed to coordinate type-3 Cu sites. The Cu-copolymers show a 6-8-fold activity enhancement, compared to the molecular complex of Cu with an identical coordination site. Michaelis-Menten analysis demonstrates that the kinetic enhancement results from flexible polymer-promoted cooperative catalysis among multi-Cu sites despite the imposed thermodynamic barrier. These observations provide guidance for the bioinspired design of metallopolymers as soluble catalysts with high activity.

The aggressive primary brain tumor glioblastoma (GBM) is characterized by aberrant metabolism that fuels its malignant phenotype. Diverse genetic subtypes of malignant glioma are sensitive to selective inhibition of the NAD+ salvage pathway enzyme nicotinamide phosphoribosyltransferase (NAMPT). However, the potential impact of NAD+ depletion on the brain tumor microenvironment has not been elaborated. In addition, systemic toxicity of NAMPT inhibition remains a significant concern. Here we show that microparticle-mediated intratumoral delivery of NAMPT inhibitor GMX1778 induces specific immunologic changes in the tumor microenvironment of murine GBM, characterized by upregulation of immune checkpoint PD-L1, recruitment of CD3+, CD4+, and CD8+ T cells, and reduction of M2-polarized immunosuppressive macrophages. NAD+ depletion and autophagy induced by NAMPT inhibitors mediated the upregulation of PD-L1 transcripts and cell surface protein levels in GBM cells. NAMPT inhibitor modulation of the tumor immune microenvironment was therefore combined with PD-1 checkpoint blockade in vivo, significantly increasing the survival of GBM-bearing animals. Thus, the therapeutic impacts of NAMPT inhibition extended beyond neoplastic cells, shaping surrounding immune effectors. Microparticle delivery and release of NAMPT inhibitor at the tumor site offers a safe and robust means to alter an immune tumor microenvironment that could potentiate checkpoint immunotherapy for glioblastoma. SIGNIFICANCE: Microparticle-mediated local inhibition of NAMPT modulates the tumor immune microenvironment and acts cooperatively with anti-PD-1 checkpoint blockade, offering a combination immunotherapy strategy for the treatment of GBM.

Au is one of the most promising electrocatalysts to convert CO2 into CO in an aqueous-phase electrochemical reduction. However, ultrasmall Au nanocatalysts (AuNCs,2 nm) have proven to be favorable for water reduction over CO2, although they possess a large surface-to-volume ratio and potentially are ideal for CO2 reduction. We herein report that ultrasmall AuNCs (1.9 ± 0.3 nm) supported on nitrided carbon are remarkably active and selective for CO2 reduction. The mass activity for CO of AuNCs reaches 967 A g-1 with a faradaic efficiency for CO of ∼83% at -0.73 V (vs. reversible hydrogen electrode) that is an order of magnitude more active than the state-of-the-art results. The high activity is endowed by the large surface area per unit weight and the high selectivity of ultrasmall AuNCs for CO2 reduction originates from the cooperative effect of Au and the nitrided carbon support where the surface N sites act as Lewis bases to increase the surface charge density of AuNCs and enhance the localized concentration of CO2 nearby catalytically active Au sites. We show that our results can be applied to other pre-synthesized Au catalysts to largely improve their selectivity for CO2 reduction by 50%. Our method is expected to illustrate a general guideline to effectively lower the cost of Au catalysts per unit weight of the product while maintaining its high selectivity for CO2 reduction.

New synthetic methods capable of controlling structural and compositional complexities of asymmetric nanoparticles (NPs) are very challenging but highly desired. A simple and general synthetic approach to designing sophisticated asymmetric NPs by anisotropically patterning the surface of isotropic metallic NPs with amphiphilic block copolymers (BCPs) is reported. The selective galvanic replacement and seed-mediated growth of a second metal can be achieved on the exposed surface of metal NPs, resulting in the formation of nanobowls and Janus-type metal-metal dimers, respectively. Using Ag and Au NPs tethered with amphiphilic block copolymers of poly(ethylene oxide)-block-polystyrene (PEO-b-PS), anisotropic surface patterning of metallic NPs (e.g., Ag and Au) is shown to be driven by thermodynamical phase segregation of BCP ligands on isotropic metal NPs. Two proof-of-concept experiments are given on, i) synthesis of Au nanobowls by a selective galvanic replacement reaction on Janus-type patched Ag/polymer NPs; and ii) preparation of Au-Pd heterodimers and Au-Au homodimers by a seed-mediated growth on Janus-type patched Au/polymer NPs. The method shows remarkable versatility; and it can be easily handled in aqueous solution. This synthetic strategy stands out as the new methodology to design and synthesis asymmetric metal NPs with sophisticated topologies.